Transgene Biotek Ltd.
Fundamentals
- Market cap
- ₹24.02 cr
- ROE
- 0.00%
- Debt / equity
- 1.45
- 52-week range
- 1.83 — 5.26
The timeline — 2 notes on Transgene Biotek Ltd.
May 2026
- 29 May 26 · 4:05 PM IST Brief Brief · Earnings · Micro cap
Transgene Biotek reports widening losses and negative equity in FY26
The company's revenue dropped to ₹21.12 lakhs as net losses more than doubled. Litigation with SEBI, ED, and NCLT remains ongoing.
- 29 May 26 · 3:19 PM IST Brief Brief · Earnings · Micro cap
Transgene Biotek reports ₹21 lakh revenue as legal battles drag on
The nano-cap firm posted a net loss of ₹165.29 lakhs for FY26, with auditors flagging a material risk to its status as a going concern.